Exact Mass: 335.1281

Exact Mass Matches: 335.1281

Found 129 metabolites which its exact mass value is equals to given mass value 335.1281, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-acetylglucosaminylasparagine

(2S)-2-amino-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl}propanoic acid

C12H21N3O8 (335.1329)


Aspartylglycosamine, also known as n4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine or 1-beta-aspartyl-N-acetyl-D-glucosaminylamine, is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine can be found primarily in urine, as well as in human spleen tissue. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Moreover, aspartylglycosamine is found to be associated with aspartylglucosaminuria, which is an inborn error of metabolism. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria corresponding to decreased activity of aspartylglycosamine amido hydrolase. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria, which is a metabolic disorder associated with decreased activity of aspartylglycosamine amido hydrolase. [HMDB]

   

Tryptophyl-Methionine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-(methylsulphanyl)butanoic acid

C16H21N3O3S (335.1304)


Tryptophyl-Methionine is a dipeptide composed of tryptophan and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Tryptophan

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


Methionyl-Tryptophan is a dipeptide composed of methionine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

25C-NBOMe

2-(4-Chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine

C18H22ClNO3 (335.1288)


   

Cloquintocet-mexyl

1-Methylhexyl 2-[(5-chloro-8-quinolinyl)oxy]acetic acid

C18H22ClNO3 (335.1288)


   

Diethylenetriaminetetraacetic acid

2-{[2-({2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid

C12H21N3O8 (335.1329)


   

1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan

N-[(4,5-dimethyl-1,3-thiazol-2-yl)imino]-N-(phenylamino)benzenecarboximidamide

C18H17N5S (335.1205)


   

Ramixotidine

N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-1-oxo-1-pyridine-3-carboximidic acid

C16H21N3O3S (335.1304)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

3-[(2-Aminoethylamino)methyl]-3-[bis(carboxymethyl)amino]pentanedioic acid

3-{[(2-aminoethyl)amino]methyl}-3-[bis(carboxymethyl)amino]pentanedioic acid

C12H21N3O8 (335.1329)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

2-(4,5-dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2,3-dihydro-1H-1,2,3,4-tetrazole

C18H17N5S (335.1205)


   

7,8-Dimethoxymyrtopsine

(+)-7,8-Dimethoxymyrtopsine

C17H21NO6 (335.1369)


   

Eremofortin E

Eremofortin E

C17H21NO6 (335.1369)


   
   
   
   

Hydroxylunidine

Hydroxylunidine

C17H21NO6 (335.1369)


   

Cloquintocet-mexyl

Cloquintocet-mexyl

C18H22ClNO3 (335.1288)


CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10219; ORIGINAL_PRECURSOR_SCAN_NO 10218 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10248; ORIGINAL_PRECURSOR_SCAN_NO 10246 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10275; ORIGINAL_PRECURSOR_SCAN_NO 10273 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10288; ORIGINAL_PRECURSOR_SCAN_NO 10286 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10259; ORIGINAL_PRECURSOR_SCAN_NO 10258 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10304; ORIGINAL_PRECURSOR_SCAN_NO 10302

   
   

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

2-Amino-3-({4-[4-(tert-butyl)-1,3-thiazol-2-yl]benzylidene}amino)but-2-enedinitrile

C18H17N5S (335.1205)


   
   

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-thienyl)-, diethyl ester

C17H21NO4S (335.1191)


   
   
   
   

hydroxymethylmycophenolic acid amide

hydroxymethylmycophenolic acid amide

C17H21NO6 (335.1369)


   

Araliopsinine

Araliopsinine

C17H21NO6 (335.1369)


   
   

7-methoxycrinamabine

7-methoxycrinamabine

C17H21NO6 (335.1369)


   
   

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

C17H21NO6 (335.1369)


   
   
   
   
   
   
   
   
   
   

Desethylene-N-acetylnorfloxacin

Desethylene-N-acetylnorfloxacin

C16H18FN3O4 (335.1281)


   
   
   

Aspartylglycosamine

Aspartylglycosamine

C12H21N3O8 (335.1329)


   

Met-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H21N3O3S (335.1304)


A dipeptide formed from L-methionine and L-tryptophan residues.

   

TRP-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


   

mtt formazan

mtt formazan

C18H17N5S (335.1205)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D005562 - Formazans

   

Methionyltryptophan

Methionyltryptophan

C16H21N3O3S (335.1304)


   

codeine hydrochloride

codeine hydrochloride

C18H22ClNO3 (335.1288)


   

SEMPERVIRINE, NITRATE, DIHYDRATE

SEMPERVIRINE, NITRATE, DIHYDRATE

C19H17N3O3 (335.127)


   

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

C17H16F3N3O (335.1245)


   

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

2C-C-NBOMe

N-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

C21H18FNO2 (335.1321)


   

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

Boc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid

C17H21NO4S (335.1191)


   

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

C18H22ClNO3 (335.1288)


   

Levofloxacin Related Compound E

Levofloxacin Related Compound E

C16H18FN3O4 (335.1281)


   

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

C24H17NO (335.131)


   

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

C18H22ClNO3 (335.1288)


   

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

C24H17NO (335.131)


   

ML-167

(5-(4-(((5-Methylfuran-2-yl)methyl)amino)quinazolin-6-yl)furan-2-yl)methanol

C19H17N3O3 (335.127)


   

Despropylene Gatifloxacin

Despropylene Gatifloxacin

C16H18FN3O4 (335.1281)


   
   
   

L-Methionine, L-tryptophyl-

L-Methionine, L-tryptophyl-

C16H21N3O3S (335.1304)


   

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

N2-(4-fluorophenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

C18H14FN5O (335.1182)


   

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

C19H17N3O3 (335.127)


   

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

C16H21N3O3S (335.1304)


   
   

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

C19H17N3O3 (335.127)


   

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

C12H21N3O8 (335.1329)


Zwitterionic form of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

a Steroid sulfate

a Steroid sulfate

C18H23O4S- (335.1317)


   

Diaminobutyryl-citryl-ethanolamine

Diaminobutyryl-citryl-ethanolamine

C12H21N3O8 (335.1329)


   

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

C12H21N3O8 (335.1329)


   

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2,3-dihydro-1H-tetrazole

C18H17N5S (335.1205)


   

Thr-Thr-Asp

Thr-Thr-Asp

C12H21N3O8 (335.1329)


A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.

   

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

C19H17N3O3 (335.127)


   

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

C19H17N3O3 (335.127)


   

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

C19H17N3O3 (335.127)


   

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

C19H17N3O3 (335.127)


   

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-4-methoxybenzenesulfonamide

C17H21NO4S (335.1191)


   

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

ethyl 2-{[(E)-(4,4-dimethyl-2,6-dioxocyclohexyl)methylidene]amino}-5-methylthiophene-3-carboxylate

C17H21NO4S (335.1191)


   

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

C19H17N3O3 (335.127)


   

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   
   

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H17N3O3 (335.127)


   

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288)


   
   
   
   
   
   
   
   

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

C19H17N3O3 (335.127)


   

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

C19H17N3O3 (335.127)


   

4-Benzoyl-2,6-diphenylpyridine

4-Benzoyl-2,6-diphenylpyridine

C24H17NO (335.131)


   

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C19H17N3O3 (335.127)


   

N-Acetylglucosaminylasparagine

N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine

C12H21N3O8 (335.1329)


An N(4)-glycosyl-L-asparagine having (beta-N-acetyl-D-glucosaminyl as the glycosyl component.

   

tryptophylmethionine

tryptophylmethionine

C16H21N3O3S (335.1304)


   

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288)


   

AMPA receptor modulator-3

AMPA receptor modulator-3

C18H22FNO2S (335.1355)


AMPA receptor modulator-3 is an allosteric AMPA receptor modulator (EC50: 4.4 μM). AMPA receptor modulator-3 can be used in the research of mammalian nervous system, such as learning and memory[1][2].

   

LAS101057

LAS101057

C18H14FN5O (335.1182)


LAS101057 is a potent, selective, and orally efficacious A2B receptor antagonist.

   

Longdaysin

Longdaysin

C16H16F3N5 (335.1358)


Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of? 5.6 μM, 8.8 μM, 29 μM, and 52 μM, respectively[1][2].

   

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

C16H21N3O3S (335.1304)


   

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   
   

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

methyl 2-{[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

C19H17N3O3 (335.127)


   

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

C12H21N3O8 (335.1329)


   

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

C17H21NO6 (335.1369)


   

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

C12H21N3O8 (335.1329)


   

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

methyl 2-({9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl}amino)benzoate

C19H17N3O3 (335.127)


   

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

3-(4-hydroxyphenyl)-5-[2-(methylamino)ethyl]-1h,7h-pyrrolo[3,2-f]indole-4,8-dione

C19H17N3O3 (335.127)


   

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)